Company Profile
Myomo Stock Price, News & Analysis
- Ticker:
- MYO
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.31 USD (+23.58%)
Close
Last updated: August 6, 2026
41M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, MYO closed up 23.6% at $1.31. No new same-company headline was identified in the current news window.
Company overview
Business overview
Myomo is a medical robotics company focused on powered orthotic devices that help patients with upper-limb impairment. Its business is centered on assistive technology rather than biotech therapeutics.
Geographic Base and Sector Classification
Myomo is headquartered in the United States and listed on NYSE American. It sits in medical devices and rehabilitation technology.
Business Model Characteristics
The company depends on product adoption, reimbursement, and the ability to scale its assistive-device platform. Investors watch commercial execution, insurance access, and unit growth.
Position Within the Biotechnology Landscape
Myomo is outside biotech and belongs in the rehab-device category. Its stock is driven by device adoption and reimbursement rather than drug or trial catalysts.
Future catalysts
Myomo’s catalysts are assistive-device adoption, reimbursement, and continued growth in neuro-orthopedic support. The business improves when the device base keeps widening.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Myomo (MYO)?
Myomo (MYO) most recently closed at 1.31 USD, a +23.58% move versus the previous session.
What is the market cap of Myomo (MYO)?
Myomo currently has a market capitalization of 41M USD on BioPharmSignal.
What does Myomo do?
Myomo is a medical robotics company focused on powered orthotic devices that help patients with upper-limb impairment. Its business is centered on assistive technology rather than biotech therapeutics.
On which exchange is MYO stock listed?
Myomo (MYO) is associated with NYSE, United States, Biopharma.
What is Myomo?
Myomo’s catalysts are assistive-device adoption, reimbursement, and continued growth in neuro-orthopedic support.
Which conditions is Myomo targeting with Myomo?
Myomo’s catalysts are assistive-device adoption, reimbursement, and continued growth in neuro-orthopedic support.
How does Myomo describe recent progress with Myomo?
Myomo’s catalysts are assistive-device adoption, reimbursement, and continued growth in neuro-orthopedic support.
What future catalysts are investors watching for Myomo?
Myomo’s catalysts are assistive-device adoption, reimbursement, and continued growth in neuro-orthopedic support. The business improves when the device base keeps widening.